The present disclosure relates to DNA-PK inhibiting compounds and prodrugs thereof that are useful in the treatment of diseases, including cancer. In particular, the compounds sensitise cancers to therapies such as chemotherapy and radiotherapy.
-
Paragraph 00218
(2021/03/19)
More Articles about upstream products of 19556-97-9